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Objective: Due to the rapid proliferation of human immunodeficiency virus (HIV) treatment 
options, there is a need for health care providers with knowledge of antiretroviral therapy 
  intricacies. In a HIV multidisciplinary care team, the HIV pharmacist is well-equipped to   provide 
this expertise. We conducted a systematic review to assess the impact of HIV pharmacists on 
HIV clinical outcomes.
Methods: We searched six electronic databases from January 1, 1980 to June 1, 2011 and 
included all quantitative studies that examined pharmacist’s roles in the clinical care of HIV-
positive adults. Primary outcomes were antiretroviral adherence, viral load, and CD4
+ cell count 
and secondary outcomes included health care utilization parameters, antiretroviral modifications, 
and other descriptive variables.
Results: Thirty-two publications were included. Despite methodological limitation, the involve-
ment of HIV pharmacists was associated with statistically significant adherence improvements 
and positive impact on viral suppression in the majority of studies.
Conclusion: This systematic review provides evidence of the beneficial impact of HIV phar-
macists on HIV treatment outcomes and offers suggestions for future research.
Keywords: pharmacist, HIV/AIDS, clinical, adherence, impact
Introduction
Since the first reported cases of AIDS in 19811 and the emergence of the global human 
immunodeficiency virus (HIV) pandemic, the field of antiretroviral (ARV) therapy 
has undergone extraordinary changes and continues to witness dramatic progress. 
The availability of over two dozen distinct ARVs, providing more tolerable and safer 
agents, and the ability to tailor ARV regimens to individual patients, demonstrates the 
substantial advancement in the field and the heightened understanding and expertise 
that is required to minimize drug interactions, contraindications, and adverse effects. 
The increased incidence of comorbidities in the aging HIV-positive population demands 
close monitoring and a keen awareness of the interplay between various therapies, the 
transmission of drug resistant viruses requires knowledge of ARV regimen selection, 
and the need for life-long therapy necessitates high ARV adherence and long-term 
follow-up. Therefore, the HIV clinical pharmacist has emerged as an indispensable 
member of the HIV multidisciplinary care team.
Publications as early as 1991 have described the involvement of pharmacists in 
clinics and hospital teams caring for HIV-positive individuals.2–4 These and other 
studies5,6 demonstrate the importance of the pharmacist’s medication expertise and 
involvement in the multidisciplinary care team. Most recently, Horberg et al7 examined 
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the components of the HIV multidisciplinary care team that 
are associated with the greatest increases in ARV adherence. 
The involvement of clinical pharmacists represented the first 
branch of the regression tree (signifying the component of 
the care team with the greatest impact on adherence) and 
the presence of clinical pharmacists resulted in statistically 
significant improvements in adherence in conjunction with 
any multidisciplinary care team member.
Given the extensive history and indications that clinical 
pharmacists may be particularly valuable in the medical 
care of HIV-positive individuals, we conducted a systematic 
review to assess the contributions of HIV pharmacists on HIV 
clinical outcomes, including ARV adherence and virologic 
and immunologic parameters. The purpose of this review 
was to systematically evaluate the research conducted to date 
and identify gaps in our knowledge regarding the impact of 




The primary objective of this systematic review was to 
evaluate the impact of clinical pharmacists on HIV clinical 
outcomes. Primary outcomes included ARV adherence, 
HIV viral load suppression, and CD4
+ cell count. Secondary 
outcomes consisted of health care utilization parameters, anti-
retroviral modifications, and other descriptive variables.
Data sources
We searched PubMed, EMBASE®, Cochrane Library, Web 
of Science®, BIOSIS Previews, and PsycINFO® from 1980 
(or the respective date of inception of each database) until 
June 1, 2011. Additionally, we conducted a manual search by 
screening the references of pertinent articles and identifying 
any additional relevant publications that were not previously 
included. Due to incomplete data presentation in conference 
abstracts, we did not include conference proceedings and 
abstracts in this review.
Search strategy
We conducted our search strategy in the style of Cochrane 
Highly Sensitive Search Strategy to identify all   relevant 
  published studies.8  We  included  randomized  and 
  nonrandomized controlled trials, before-after comparisons, 
historically controlled trials, cohort studies, cross-sectional 
studies, case-control studies, and descriptive studies, as well 
as appropriate medical subject headings (MeSH) terms, 
and a wide range of relevant search terms in all databases. 
The detailed search strategy used for PubMed can be found 
in Table 1. This strategy was modified as appropriate for use 
in other databases.
Inclusion and exclusion criteria
We included all studies that examined the role of a phar-
macist in the clinical care of HIV-infected adults.   Studies 
were divided into two broad categories based on the 
  researchers’ prespecified intentions in examining the impact 
of   pharmacists. The first category encompassed “intervention 
studies”; these studies included HIV pharmacist activities that 
were part of a study protocol and were only implemented for 
the purpose of research upon receipt of informed consent. The 
second category included studies of “clinical care activities”; 
defined as studies which examined pharmacist actions that 
were taken as part of routine patient care and which examined 
specific outcomes (eg, the impact of an existing pharmacist 
adherence clinic on adherence). These clinical care activities 
were not conducted for the purpose of research and would 
have occurred regardless of the study. The reason for this 
classification was to assess the rigor of the research and the 
evolution of publications regarding HIV clinical pharmacists 
over time. Studies that did not include details of the pharma-
cist’s involvement, but specifically mentioned any pharmacist 
participation were included. Multifactorial interventions or 
clinical care activities were included as long as at least one 
factor clearly indicated pharmacist contributions.
We also classified the pharmacist role as being central 
or peripheral to the study objectives. The pharmacist role 
was considered “central” in studies that were specifically 
designed to examine the influence of pharmacists on the 
care of HIV-positive individuals. Studies where the role of 
the pharmacist was “peripheral” were those in which the 
pharmacist was involved in carrying out the study objectives, 
but the research was not designed to examine the sole impact 
of the pharmacist.
We did not include studies that exclusively assessed phar-
macist’s ability to provide HIV prevention services or studies 
that only assessed pharmacy operations (such as medication 
stock, home delivery, medication packaging, etc). Studies 
were included without regard to the location where they were 
conducted, but were limited to English language publications. 
Research that was purely qualitative was excluded.
Review methods and data 
abstraction
Using EndNote software package (X5.0.1; Thomson 
  Reuters, New York, NY) relevant studies were located 
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change in patients’ or providers’ HIV knowledge, impact 
on ARV drug resistance, and reports of the number of 
clinical care activities conducted by the pharmacist (eg, 
identification of dose errors, initiation/discontinuation/
consolidation of ARVs, adverse effect and drug interac-
tion detection and management, resolution of medication 
adherence issues, and provision of drug information). 
Given the variability in assessment, analysis, and presenta-
tion of outcomes in identified studies, we were unable to 
conduct a meta-analysis.
Results
From 1545 search matches, 68 articles were assessed for 
eligibility and, of these, 36 were excluded because they were 
published in a language other than English (n = 3), were in 
abstract form (n = 11), were review articles (n = 3), were 
qualitative studies (n = 4), or were not regarding pharmacist 
clinical care activities or intervention (n = 15) (Figure 1). 
Thirty-two publications met our eligibility criteria and were 
included.10–41 Among these publications, 19 evaluated the 
  primary outcomes of interest10–28 and 13 contained informa-
tion on the secondary outcomes.29–41 Tables 2 and 3 sum-
marize these studies.
Table 1 Example of search strategy used in PubMed
Search # PubMed search terms
#7 Search #5 AND #6
#6 Search randomized controlled trial[pt] OR controlled clinical trial[pt] OR randomized controlled trials[mh] OR random 
allocation[mh] OR double-blind method[mh] OR single-blind method[mh] OR clinical trial[pt] OR clinical trials[mh] OR “clinical 
trial”[tw] OR ((singl*[tw] OR doubl*[tw] OR trebl*[tw] OR tripl*[tw]) AND (mask*[tw] OR blind*[tw])) OR Placebos[mh] OR 
placebo*[tw] OR random*[tw] OR nonrandomi*[tw] OR before after study[tw] OR time series[tw] OR “case control”[tw] OR 
prospective*[tw] OR retrospective*[tw] OR cohort[tw] OR cross-section*[tw] OR research design[mh:noexp] OR comparative 
study[pt] OR evaluation studies[pt] OR follow-up studies[mh] OR prospective studies[mh] OR controlled[tw] OR control[tw] OR 
volunteer*[tw] OR longitud*[tw] OR descripti*[tiab] OR study[tiab] OR evaluat*[tiab] OR “odds ratio”[tw] OR “hazard ratio”[tw] 
OR “relative risk”[tw] OR “risk ratio”[tw] OR AOR[tiab] OR RRR[tiab] OR NNT[tiab] OR design*[tiab]
#5 Search #1 AND #2 AND #3 AND #4
#4 Search HAART[tiab] OR ART[tiab] OR ARV[tiab] OR ARVs[tiab] OR anti-retroviral*[tiab] OR antiretroviral*[tiab] OR “anti-
viral”[tiab] OR antiviral[tiab] OR “anti-HIV” OR antiHIV OR “Antiretroviral Therapy, Highly Active”[mh] OR “Anti-Retroviral 
Agents”[mh] OR CD4[tw] OR immune[tw] OR immunolo*[tw] OR immunology[sh] OR lymphocyte[tw] OR CD4-Positive 
T-Lymphocytes[mh] OR CD4 Lymphocyte Count[mh] OR CD4 count* OR “viral load”[tw] OR virol*[tw] OR viral[tw] OR 
virology[sh] OR outcome OR outcomes OR prognosis OR “outcome and process assessment(health care)”[mh] OR th[sh:noexp] 
OR dt[sh] OR effective*[tw]
#3 Search adhere*[tiab] OR complian*[tiab] OR adhere*[tw] OR complian*[tw] OR Patient Compliance[mh] OR Medication 
Adherence[mh] OR Counseling[mh] OR counsel*[tw] OR education[tw] OR monitor*[tw] OR interven*[tw] OR self 
administration[mh]
#2 Search pharmacist*[tiab] OR PharmD[tiab] OR “Pharm D”[tiab] OR pharmacy[tiab] OR pharmacies[tiab] OR pharmacists[mh] OR 
pharmacy[mh] OR community pharmacy services[mh] OR medication therapy management[mh] OR pharmacy service, hospital[mh] 
OR pharmaceutical services[mh:noexp]
#1 Search HIV Infections[mh] OR HIV[mh] OR HIV[tiab] OR HIV-1[tiab] OR HIV-2[tiab] OR HIV-1[tiab] OR HIV-2[tiab] OR HIV 
infect*[tiab] OR human immunodeficiency virus[tiab] OR human immune deficiency virus[tiab] OR human immuno-deficiency 
virus[tiab] OR ((human immun*) AND (deficiency virus[tiab])) OR acquired immunodeficiency syndrome[tiab] OR acquired 
immune deficiency syndrome[tiab] OR acquired immuno-deficiency syndrome[tiab] OR ((acquired immun*) AND (deficiency 
syndrome[tiab])) OR HIV/AIDS[tiab] OR “HIV AIDS”[tiab] OR “Sexually Transmitted Diseases, Viral”[mh]
in the above-mentioned data sources and duplicates and 
irrelevant articles were extracted by one author (PS). Two 
authors (PS, JC) independently read the remaining cita-
tions and identified eligible studies based on prespecified 
inclusion/exclusion criteria. All uncertainties and disagree-
ments were arbitrated by a third author (BD). Using a data 
abstraction form, three authors (PS, JC, BD) summarized 
pertinent information from included articles and over 30% 
of all abstracted data was re-examined by another author 
to ensure data accuracy. We utilized the Cochrane guide 
for study assessment checklist to assign the study design 
to each included study.9
Outcome variables
The primary outcome of this review focused on the impact 
of the pharmacist on ARV adherence, HIV viral load, and 
CD4
+ cell count. Secondary outcomes included change in 
the number of physician or emergency room visits, change 
in pill burden (ie, frequency of daily dosing or quantity of 
pills per day), cost effectiveness or any cost containment 
data, discontinuation or initiation of opportunistic infec-
tion prophylaxis or treatment, percentage of clinical care 
activities accepted by the attending physician or team, 
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Publications evaluating HIV clinical 
pharmacists’ impact on primary 
outcomes
These studies were published between 2000 and 2011 and 
were primarily conducted in the US (68%). Observational 
cohort studies (32%) and before-after comparisons (32%) 
were the most common study designs. Baseline sample 
sizes ranged from 28 to 7018 (median = 64); in studies 
that reported mean age, participant mean age ranged from 
36 years to 49 years; and the percentage of male study par-
ticipants ranged from 0% to 100% (median = 80%). The 
percentage of participants who were Black ranged from 
15% to 83% (median = 26%; not stated in 32% of studies); 
the proportion of White participants ranged from 12% to 
71% (median = 52%; not stated in 32% of studies); and the 
  percentage of men who have sex with men (MSM) ranged 
from 0% to 70% (median = 51%; not stated in 47% of   studies). 
The pharmacist played a central role in the study objectives 
of 53% of included publications11,14,15,17,20,21,24,25,27,28 and 63% 
of studies examined the impact of pharmacist interventions 
(see Methods section for definition).10–13,15,17,19,20,22–24,26
The majority of the reviewed studies examined the 
impact of pharmacists in HIV ambulatory care clinic 
setting (63%),10–12,15–21,25,28 followed by outpatient com-
munity pharmacies (26%).14,22,24,26,27 The main pharmacist 
role was the provision of medication adherence coun-
seling and tools for adherence improvement (including 
pill boxes, refill reminders, beepers, alarms, medication 
schedules, blister packs, medication diaries, etc). Other 
pharmacist activities included patient education (regard-
ing dosing, adverse effects, drug interactions, medication 
storage, missed doses, adherence, methods of improving 
  adherence, etc); ARV regimen selection; ARV initiation, 
discontinuation, and dose adjustment for renal/hepatic 
impairment; and monitoring for ARV adverse effects and 
drug interactions.
1542 studies identified through
electronic search
3 additional records identified
through manual search





32 studies included in
systematic review












































13 studies with secondary
outcomes
19 studies with primary
outcomes
Figure 1 Selection process for study inclusion.
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ARV adherence
In the 18 studies that examined ARV adherence10–19,21–28 
(adherence not assessed in March et al20), the most 
common method of adherence assessment was based 
on medication refill records (56%), followed by patient 
self-report (33%), and electronic drug monitoring using 
medication event monitoring systems (MEMS®, 28%). 
Other less frequently used methods included pill count and 
therapeutic drug level monitoring. Approximately 78% of 
studies used only one adherence assessment method and 
17% used two methods.
Among the 10 publications in which the pharmacist’s 
role was central,11,14,15,17,20,21,24,25,27,28 adherence was com-
pared between the pharmacist group versus a control 
group in eight studies;11,14,15,17,21,25,27,28 all of which found an 
association between assignment to the pharmacist group 
and improved adherence outcomes. Nine studies examined 
interventions or clinical care activities where the pharma-
cist had a peripheral role,10,12,13,16,18,19,22,23,26 among which 
five reported medication adherence outcomes by comparing 
the pharmacist group versus a control group.13,16,18,22,26 Four 
of these studies reported a positive association between 
adherence and allocation to the pharmacist group13,16,22,26 
and one showed no statistically significant difference 
between the two arms.18
Among 13 studies that compared adherence outcomes 
of a pharmacist-engaged study arm versus a control 
arm,11,13–18,21,22,24–26,28 nine reported percent ARV adherence 
as a continuous outcome in each group at the end of the 
follow-up period.11,13,16–18,21,24–26 In these studies, adher-
ence in the pharmacist arm was 2%–59% (median = 19%) 
higher as compared to the control arm. Four studies used 
other methods of comparison to present the impact of 
pharmacist care on adherence.14,15,22,28 Castillo et al,14 found 
that 14.7% more patients who obtained service from AIDS 
tertiary care hospital pharmacies had .90% adherence 
compared to those with no pharmacist contact. Hirsch 
et al,22 found that 18.2% more patients receiving ARVs 
from pilot Medi-Cal pharmacies, featuring pharmacists 
with HIV training, had an adherence of 80%–120% in 
comparison to those not enrolled in this program. In a 
study by Henderson et al,28 25% more patients had .95% 
adherence after referral to the pharmacist-managed clinic 
versus prior to referral. Lastly, Levy et al15 reported that 
participants missed 1.2 fewer doses in the past 7 days 
after receipt of a pharmacist-provided adherence educa-
tion session versus the period of observation prior to this 
intervention.
HIV viral load
Among the ten studies that assessed the central role of 
the pharmacist,11,14,15,17,20,21,24,25,27,28 nine examined viral 
load outcomes.11,14,15,17,20,21,25,27,28 In six of these studies, 
  pharmacist involvement was associated with clinically or 
statistically significant viral load reductions or a greater 
proportion of maximal viral suppression,14,17,20,21,25,28 
while in three, no association with pharmacist care was 
observed.11,15,27 The pharmacist assumed a peripheral role 
in nine studies,10,12,13,16,18,19,22,23,26 among which five reported 
virologic outcomes.12,13,18,19,23 In four of these studies, a 
favorable association was noted between viral load reduction 
and allocation to the pharmacist-involved study arm,12,13,18,23 
whereas no relationship between virologic response and 
pharmacist care was reported by one study.19
CD4
+ cell count
In the ten studies where a pharmacist played a central role, 
seven also assessed immunologic outcomes.11,15,17,20,21,25,27 
Among these studies, two revealed an increase in CD4
+ cell 
count related to receipt of pharmacist care20,25 and five showed 
no association.11,15,17,21,27 Of the nine studies in which the phar-
macist had a peripheral role, only two reported immunologic 
outcomes18,19 and in both no relationship was seen between 
the pharmacist arm versus the control arm.
Other outcomes
Among the ten studies investigating the pharmacist’s central 
role, several reported other favorable outcomes, including an 
increase in adherence to clinic appointments and reductions in 
variables such as hospitalizations,11 ARV toxicity scores,20 phy-
sician office visits, number of hospital days, emergency depart-
ment visits,21 pill burden, and daily dosing frequency.25 Other 
outcomes in the nine studies where the pharmacist assumed a 
peripheral role included no changes in variables such as ARV 
adherence self-efficacy,13 retention on ARV at 12 months,18 and 
frequency of incident opportunistic infections.22,26 However, 
there were increases in the time on ARV therapy,18 improved 
appointment keeping,19 higher likelihood of remaining on 
A RV, 22,26 fewer contraindicated ARV regimens,22,26 and a higher 
cost in the study arm involving the pharmacist.19,22
Publications evaluating HIV clinical 
pharmacists’ impact on secondary 
outcomes
These studies were published between 1992 and 2011 and 
69% were conducted in the US. Approximately 80% of these 
studies were descriptive in nature. Baseline sample sizes 















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































ranged from 31 to 285 (median = 70); in studies reporting 
mean age, participant mean age ranged from 36 years to 
65 years (age not stated in 38% of studies); percentage of male 
study participants ranged from 49% to 100% (median = 71%; 
not stated in 31% of studies). The percentage of participants 
who were Black ranged from 27% to 82% (median = 53%; 
not stated in 69% of studies); proportion of participants who 
were White ranged from 18% to 53% (median = 20%; not 
stated in 62% of studies); and percentage of MSM ranged 
from 6% to 26% (not stated in 85% of studies).
In 92% of these studies, the central role of a pharmacist 
was evaluated29 -38,40,41 and approximately 85%–100% of the 
pharmacists’ suggestions were accepted by the physician or 
health care team. Sixty-nine percent of studies examined 
pharmacists’ impact in the inpatient medical center set-
ting30–32,34,37–41 and 23% assessed this role in the outpatient 
ambulatory care clinics.29,33,35 The clinical care activities 
performed by pharmacists in these reports included adjust-
ments in drug doses, medication initiation/discontinuation, 
monitoring and prevention of drug interactions or adverse 
drug reactions, and the provision of drug information and 
medication counseling.
In one study, the researchers noted an improvement in 
the inpatient documentation of outpatient medications, a 
reduction in inappropriate discontinuation of outpatient 
medications, and an increase in ARV prescription accuracy 
for inpatients.40 Another study examined the benefits of 
pharmacists on the inpatient service and reported a substan-
tial reduction in the length of time taken to correct an ARV 
error.38 Conversely, in the only study that examined the effect 
of a pharmacist’s interventions (see Methods for definition), 
the reduction in the number of drug interactions between 
patients whose physician received only their medication list 
was no different from those whose physician received both 
the medication list and the pharmacist’s drug interaction 
notification and management suggestions.35
Discussion
In this systematic review, we evaluated the impact of HIV 
pharmacists on HIV clinical outcomes, health utiliza-
tion measures, ARV modifications, and other descriptive 
  variables. In all but one study,18 the involvement of an HIV 
pharmacist in patient care was associated with clinically and 
statistically significant improvements in ARV adherence. 
The majority of reviewed studies also indicated that HIV 
pharmacist’s care was associated with greater viral load 
suppression. Evidence of any influence of pharmacists on 
immunologic outcomes was unclear and attenuated, which 








































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Impact of HIV clinical pharmacistsPatient Preference and Adherence 2012:6
may have been due to lack of reporting of CD4
+ cell count in 
many studies, insufficient duration of follow-up to observe 
substantial changes, the lack of an effect, or the more erratic 
nature of this outcome measure.
Several study-related factors limited the depth of our 
review. The most crucial limitation of several studies was the 
lack of reporting and/or adjustment for baseline demograph-
ics and confounders. The absence of reporting of clinical out-
comes data in many studies and methodological constraints, 
such as reporting adherence as dichotomous or categorical 
variables or other methods, precluded a meta-analysis. 
Other common limitations included small sample size, short 
duration of study follow-up, incomplete description of the 
pharmacist’s role or the complexity of multicomponent 
interventions, and the use of unconventional methods of 
adherence calculation. Lastly, as with any systematic review, 
there is the potential for positive publication bias influencing 
the aggregate results.
The reviewed studies provide a broad spectrum of HIV 
pharmacist activities. It is noteworthy that the majority of the 
reviewed studies were conducted in HIV ambulatory care or 
inpatient medical center settings. HIV pharmacists practic-
ing in community pharmacies are increasingly called upon 
to provide ARV adherence training, patient education, and 
drug information, yet outcome data from such activities are 
not well-represented in the literature. This may be due to the 
under-recognized value of these services or the challenges 
associated with gaining combined access to laboratory medi-
cal record and community pharmacy data.
We found a plethora of descriptive studies on ARV-
related errors identified and resolved by the pharmacist and 
the degree of acceptance of pharmacist-related activities, 
as well as observational studies on the consistent evidence 
of a positive impact of HIV clinical pharmacists on ARV 
  adherence. Therefore, future mixed methods research, 
including qualitative and quantitative studies should 
  examine the pharmacist–patient relationship, focus on 
determining crucial pharmacist functions which have the 
most impact on adherence, and test these findings in random-
ized controlled trials with large sample sizes. Additionally, 
studies should examine cost-effectiveness of pharmacists 
(including cost savings associated with improvements in 
clinical markers, as well as other outcomes, such as reduc-
tions in extraneous physician visits, emergency room visits, 
length of hospitalization, medication errors, etc). Further 
research should also expand to include HIV pharmacist 
responsibilities that are beyond the “traditional” func-
tions (ie, assessment of ARV accuracy, identification of 
drug interactions, adherence counseling, patient/provider 
education, etc). These roles may include the involvement 
of pharmacists in conducting clinical trials, performance 
of motivational interviewing, interpretation of drug resis-
tance tests and prescription of ARVs, methods of tailoring 
adherence-enhancing tools based on individual reasons for 
nonadherence, and impact on HIV prevention (eg, through 
offering pre- or post-exposure prophylaxis).
It is evident in this review that research on the impact of 
pharmacists in HIV clinical care has evolved since the first 
reports in 1992. This progression includes the use of more 
sophisticated study designs and more complex research 
questions. Continued research on HIV pharmacists’ impact 
on the clinical care of HIV-positive individuals is underway. 
In ClinicalTrials.gov and the US National Institute of Health 
Research Portfolio Online Reporting Tools database there are 
currently several ongoing studies examining the role of phar-
macists in HIV clinical care. Four of these studies pertain to 
HIV prevention by assessing and expanding the pharmacist’s 
role in services related to intravenous drug users purchasing 
syringes.42–45 Another project is assessing factors related to 
the receipt of pharmacist-provided adherence counseling and 
the impact of a counseling session based on the Information–
Motivation–Behavioral Skills model46,47 on HIV treatment 
outcomes.49 A randomized controlled trial is examining the 
impact of pharmacist care on ARV adherence.49 Lastly, eco-
nomic outcomes of an intervention comparing methods of 
offering pharmacist services are also under study.50
Conclusion
In conclusion, this systematic review provides support for the 
positive association between HIV pharmacist activities and 
improvements in ARV adherence and viral load   suppression. 
HIV pharmacist functions were related to reductions in 
hospitalization, physician office visits, number of hospital 
days, visits to the emergency department, pill burden, and 
inappropriate discontinuation of outpatient medications; as 
well as improvements in inpatient documentation of home 
medications and accuracy of ARV dosing. A high percent-
age of pharmacists’ recommendations were accepted by 
the physician or the health care team and the majority of 
the pharmacist’s functions involved ARV dosing, detection 
of drug interactions or adverse drug reactions, provision 
of drug information, ARV adherence counseling, and 
instructing on the use of adherence-enhancing tools. This 
systematic review provides further evidence that, with the 
growing number of HIV-positive individuals worldwide, 
the increasing intricacies of HIV treatment options, and the 
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shortage of physicians in resource limited settings, clinical 
pharmacists trained in HIV pharmacotherapy are invaluable 
resources and are essential members of the HIV multidis-
ciplinary care team.
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